Search
SectionsIndexSymptoms
  • Cardiovascular Disorders
  • Clinical Pharmacology
  • Critical Care Medicine
  • Dental Disorders
  • Dermatologic Disorders
  • Ear, Nose, and Throat Disorders
  • Endocrine and Metabolic Disorders
  • Eye Disorders
  • Gastrointestinal Disorders
  • Genitourinary Disorders
  • Geriatrics
  • Gynecology and Obstetrics
  • Hematology and Oncology
  • Hepatic and Biliary Disorders
  • Immunology; Allergic Disorders
  • Infectious Diseases
  • Injuries; Poisoning
  • Musculoskeletal and Connective Tissue Disorders
  • Neurologic Disorders
  • Nutritional Disorders
  • Pediatrics
  • Psychiatric Disorders
  • Pulmonary Disorders
  • Special Subjects
ABCDEFGHI
JKLMNOPQR
STUVWXYZ
  • Abdominal Pain, Acute
  • Abdominal pain, Chronic
  • Alopecia
  • Amenorrhea
  • Amnesia
  • Anosmia
  • Bleeding, Excessive
  • Breast Lumps
  • Chest Pain
  • Constipation in Adults
  • Constipation in Children
  • Cough in Adults
  • Cough in Children
  • Crying
  • Diarrhea in Adults
  • Diarrhea in Children
  • Diplopia
  • Dizziness
  • Dry Mouth
  • Dysmenorrhea
  • Dyspepsia
  • Dysphagia
  • Dyspnea
  • Dysuria
  • Earache
  • Ear Discharge
  • Edema
  • Edema During Late Pregnancy
  • Epistaxis
  • Erectile dysfunction
  • Eyelid Swelling
  • Eye Pain
  • Fever
  • Fever, Acute, in Adults
  • Fever, Chronic (FUO)
  • Fever in Infants and Children
  • Floaters
  • Gas
  • Gastrointestinal Bleeding
  • Halitosis
  • Headache
  • Hearing Loss
  • Hearing Loss: Sudden Deafness
  • Hematospermia
  • Hematuria
  • Hemoptysis
  • Hiccups
  • Hirsutism
  • Insomnia and Excessive Daytime Sleepiness
  • Itching
  • Itching, Anal
  • Jaundice in Adults
  • Jaundice in Neonates
  • Joint Pain, Monarticular
  • Joint Pain, Polyarticular
  • Knee pain
  • Lump in Throat
  • Nasal Congestion and Rhinorrhea
  • Nausea and Vomiting During Early pPregnancy
  • Nausea and Vomiting in Adults
  • Nausea and Vomiting in Infants and Children
  • Neck and Back Pain
  • Neck Mass
  • Nipple Discharge
  • Orthostatis Hypotension
  • Pain
  • Pain, Chronic
  • Palpitations
  • Pelvic Pain
  • Pelvic Pain During Early Pregnancy
  • Polyuria
  • Priapism
  • Red Eye
  • Scrotal Pain
  • Sore Throat
  • Stomatitis
  • Stridor
  • Syncope
  • Tearing
  • Tinnitus
  • Toothache
  • Tremor
  • Urinary Frequency
  • Urinary Incontinence in Adults
  • Urinary Incontinence in Children
  • Urinary Retention
  • Urticaria
  • Vaginal Bleeding
  • Vaginal Bleeding During Early Pregnancy
  • Vaginal Bleeding During Late Pregnancy
  • Vaginal Itching and Discharge
  • Vision, Blurred
  • Vision Loss, Acute
  • Weakness, Generalized
  • Wheezing
In This Topic
Dermatologic Disorders
Pigmentation Disorders
Albinism
Pathophysiology
Symptoms and Signs
Diagnosis
Treatment
Key Points
Back to Top
Resources
  • About The Merck Manual
  • Ready Reference Guides
  • Trade Names of Some Commonly Used Drugs
  • Normal Laboratory Values
  • Clinical Calculators
  • Multimedia
  • Selected Links
Manuals available online
'/home/index.html' + bookPageLink
 
'/professional/index.html'
These and other Manuals available
in print, online, and as mobile applications.

See more at MerckManuals.com
Sections in Health Care Professionals
  • Cardiovascular Disorders
  • Clinical Pharmacology
  • Critical Care Medicine
  • Dental Disorders
  • Dermatologic Disorders
  • Ear, Nose, and Throat Disorders
  • Endocrine and Metabolic Disorders
  • Eye Disorders
  • Gastrointestinal Disorders
  • Genitourinary Disorders
  • Geriatrics
  • Gynecology and Obstetrics
  • Hematology and Oncology
  • Hepatic and Biliary Disorders
  • Immunology; Allergic Disorders
  • Infectious Diseases
  • Injuries; Poisoning
  • Musculoskeletal and Connective Tissue Disorders
  • Neurologic Disorders
  • Nutritional Disorders
  • Pediatrics
  • Psychiatric Disorders
  • Pulmonary Disorders
  • Special Subjects
Chapters in Dermatologic Disorders
  • Approach to the Dermatologic Patient
  • Principles of Topical Dermatologic Therapy
  • Acne and Related Disorders
  • Bullous Diseases
  • Cornification Disorders
  • Dermatitis
  • Reactions to Sunlight
  • Psoriasis and Scaling Diseases
  • Hypersensitivity and Inflammatory Disorders
  • Sweating Disorders
  • Bacterial Skin Infections
  • Fungal Skin Infections
  • Parasitic Skin Infections
  • Viral Skin Diseases
  • Pigmentation Disorders
  • Hair Disorders
  • Nail Disorders
  • Pressure Ulcers
  • Benign Skin Tumors
  • Cancers of the Skin
Topics in Pigmentation Disorders
  • Overview of Pigmentation Disorders
  • Albinism
  • Vitiligo
  • Hyperpigmentation
Amino Acid and Organic Acid Metabolism Disorders
Are you a Patient or Caregiver?
View related content in the
Merck Manual Home Health Handbook
 
  • Merck Manual
  • >
  • Health Care Professionals
  • >
  • Dermatologic Disorders
  • >
  • Pigmentation Disorders
  • 4
 
Albinism

Share This

view related topics in this manual

Oculocutaneous albinism is an inherited defect in melanin formation that causes diffuse hypopigmentation of the skin, hair, and eyes. Ocular albinism affects the eyes and not the skin. Ocular involvement causes strabismus, nystagmus, and decreased vision. Diagnosis of oculocutaneous albinism is usually obvious from the skin examination, but ocular evaluation is necessary. No treatment for the skin involvement is available other than protection from sunlight.

Pathophysiology

Oculocutaneous albinism (OCA) is a group of rare inherited disorders in which a normal number of melanocytes are present but melanin production is absent or greatly decreased. OCA occurs in people of all races throughout the world. Cutaneous and ocular pathologies (ocular involvement) are both present. Findings in ocular involvement include abnormal optic tract development manifested by foveal hypoplasia with decreased photoreceptors and misrouting of optic chiasmal fibers. Ocular albinism (OA) does not usually affect the skin.

Photographs

Albinism (Cutaneous Findings)

Albinism (Cutaneous Findings)
Photographs

Albinism (Ocular Findings)

Albinism (Ocular Findings)

Most cases of OCA are autosomal recessive; autosomal dominant inheritance is rare. There are 4 main genetic forms:

  • Type I is caused by absent (OCA1A; 40% of all OCA) or reduced (OCA1B) tyrosinase activity; tyrosinase catalyzes several steps in melanin synthesis.
  • Type II (50% of all OCA) is caused by mutations in the P (pink-eyed) gene. The function of the P protein is not yet known. Tyrosinase activity is present.
  • Type III occurs only in people with otherwise dark skin (skin types III to V). It is caused by mutations in a tyrosinase-related protein 1 gene whose product is important in eumelanin synthesis.
  • Type IV is an extremely rare form in which the defect is in a gene that codes a membrane transporter protein. Type IV is the most common form of OCA in Japan.

OA types Nettleship-Falls (OA1) and Forsius-Eriksson (OA2) are extremely rare compared to OCA. They are inherited in an X-linked dominant fashion. Usually findings are confined to the eyes, but skin may be hypopigmented. Patients with OA1 may have late-onset sensorineural deafness.

In another group of inherited diseases, a clinical phenotype of OCA occurs in conjunction with bleeding disorders. In Hermansky-Pudlak syndrome, OCA-like findings occur with platelet abnormalities and a ceroid-lipofuscin lysosomal storage disease. This syndrome is rare except in people with family origin in Puerto Rico, where its incidence is 1 in 1800. In Chédiak-Higashi syndrome, OCA-like cutaneous and ocular findings occur, hair is silvery gray, and a decrease in platelet-dense granules results in a bleeding diathesis. Patients have severe immunodeficiency due to abnormal lymphocyte lytic granules. Progressive neurologic degeneration occurs.

Symptoms and Signs

The different genetic forms have a variety of phenotypes.

Type I (OCA1A) is classic tyrosinase-negative albinism; skin and hair are milky white, and eyes are blue-gray. Pigmentary dilution in OCA1B ranges from obvious to subtle.

Type II has phenotypes with pigmentary dilution that ranges from minimal to moderate. Pigmented nevi and lentigines may develop if skin is exposed to the sun; some lentigines become large and dark. Eye color varies greatly.

In type III, skin is brown, hair is rufous (reddish), and eye color can be blue or brown.

In type IV, the phenotype is similar to that for type II.

Patients with ocular involvement may have decreased retinal pigmentation, leading to sensitivity to light and light avoidance. In addition, nystagmus, strabismus, reduced visual acuity, and loss of binocular stereopsis likely result from defective routing of the optic fibers.

Diagnosis

  • Clinical evaluation

Diagnosis of all types of OCA and OA is based on examination of the skin and eyes. Early ocular examination may detect iris translucency, reduced retinal pigmentation, foveal hypoplasia, reduced visual acuity, strabismus, and nystagmus.

Treatment

  • Strict sun protection
  • Sometimes surgical intervention for strabismus

There is no treatment for albinism. Patients are at high risk of sunburn and skin cancers (especially squamous cell carcinoma) and should avoid direct sunlight, use sunglasses with ultraviolet (UV) filtration, wear protective clothing, and use sunscreen with a sun protection factor (SPF) of ≥ 30 that protects against UVA and UVB wavelengths (see Reactions to Sunlight: Prevention). Some surgical interventions may lessen strabismus.

Key Points

  • Oculocutaneous albinism is a group of rare, usually autosomal recessive disorders, resulting in hypopigmentation of the skin, hair, and eyes.
  • Ocular involvement causes photosensitivity and often nystagmus, strabismus, reduced visual acuity, and loss of binocular stereopsis.
  • Examine the eyes and skin to make the diagnosis.
  • Instruct patients on how to strictly protect the skin and eyes from sun exposure.

Last full review/revision November 2012 by Peter C. Schalock, MD

Content last modified December 2012

Buy the Book

Mobile Versions

Back to Top

Previous: Overview of Pigmentation Disorders

Next: Vitiligo

Audio
Figures
Photographs
Sidebars
Tables
Videos

Copyright     © 2010-2013 Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., Whitehouse Station, N.J., U.S.A.    Privacy    Terms of Use